Literature DB >> 31120875

Efficient algorithms to discover alterations with complementary functional association in cancer.

Rebecca Sarto Basso1, Dorit S Hochbaum1, Fabio Vandin2,3,4.   

Abstract

Recent large cancer studies have measured somatic alterations in an unprecedented number of tumours. These large datasets allow the identification of cancer-related sets of genetic alterations by identifying relevant combinatorial patterns. Among such patterns, mutual exclusivity has been employed by several recent methods that have shown its effectiveness in characterizing gene sets associated to cancer. Mutual exclusivity arises because of the complementarity, at the functional level, of alterations in genes which are part of a group (e.g., a pathway) performing a given function. The availability of quantitative target profiles, from genetic perturbations or from clinical phenotypes, provides additional information that can be leveraged to improve the identification of cancer related gene sets by discovering groups with complementary functional associations with such targets. In this work we study the problem of finding groups of mutually exclusive alterations associated with a quantitative (functional) target. We propose a combinatorial formulation for the problem, and prove that the associated computational problem is computationally hard. We design two algorithms to solve the problem and implement them in our tool UNCOVER. We provide analytic evidence of the effectiveness of UNCOVER in finding high-quality solutions and show experimentally that UNCOVER finds sets of alterations significantly associated with functional targets in a variety of scenarios. In particular, we show that our algorithms find sets which are better than the ones obtained by the state-of-the-art method, even when sets are evaluated using the statistical score employed by the latter. In addition, our algorithms are much faster than the state-of-the-art, allowing the analysis of large datasets of thousands of target profiles from cancer cell lines. We show that on two such datasets, one from project Achilles and one from the Genomics of Drug Sensitivity in Cancer project, UNCOVER identifies several significant gene sets with complementary functional associations with targets. Software available at: https://github.com/VandinLab/UNCOVER.

Entities:  

Mesh:

Year:  2019        PMID: 31120875      PMCID: PMC6550413          DOI: 10.1371/journal.pcbi.1006802

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.475


  42 in total

1.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Authors: 
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

2.  WeSME: uncovering mutual exclusivity of cancer drivers and beyond.

Authors:  Yoo-Ah Kim; Sanna Madan; Teresa M Przytycka
Journal:  Bioinformatics       Date:  2017-03-15       Impact factor: 6.937

Review 3.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

Review 4.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

5.  Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.

Authors:  Charles J Vaske; Stephen C Benz; J Zachary Sanborn; Dent Earl; Christopher Szeto; Jingchun Zhu; David Haussler; Joshua M Stuart
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

6.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

Review 7.  Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?

Authors:  David P Minde; Zeinab Anvarian; Stefan Gd Rüdiger; Madelon M Maurice
Journal:  Mol Cancer       Date:  2011-08-22       Impact factor: 27.401

8.  Integrated genomic characterization of oesophageal carcinoma.

Authors: 
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

9.  KEGG: new perspectives on genomes, pathways, diseases and drugs.

Authors:  Minoru Kanehisa; Miho Furumichi; Mao Tanabe; Yoko Sato; Kanae Morishima
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

10.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.

Authors:  Wanjuan Yang; Jorge Soares; Patricia Greninger; Elena J Edelman; Howard Lightfoot; Simon Forbes; Nidhi Bindal; Dave Beare; James A Smith; I Richard Thompson; Sridhar Ramaswamy; P Andrew Futreal; Daniel A Haber; Michael R Stratton; Cyril Benes; Ultan McDermott; Mathew J Garnett
Journal:  Nucleic Acids Res       Date:  2012-11-23       Impact factor: 16.971

View more
  4 in total

1.  A Network-Centric Framework for the Evaluation of Mutual Exclusivity Tests on Cancer Drivers.

Authors:  Rafsan Ahmed; Cesim Erten; Aissa Houdjedj; Hilal Kazan; Cansu Yalcin
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

2.  SuperDendrix algorithm integrates genetic dependencies and genomic alterations across pathways and cancer types.

Authors:  Tae Yoon Park; Mark D M Leiserson; Gunnar W Klau; Benjamin J Raphael
Journal:  Cell Genom       Date:  2022-02-09

3.  Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities.

Authors:  Luciano Garofano; Simona Migliozzi; Young Taek Oh; Fulvio D'Angelo; Ryan D Najac; Aram Ko; Brulinda Frangaj; Francesca Pia Caruso; Kai Yu; Jinzhou Yuan; Wenting Zhao; Anna Luisa Di Stefano; Franck Bielle; Tao Jiang; Peter Sims; Mario L Suvà; Fuchou Tang; Xiao-Dong Su; Michele Ceccarelli; Marc Sanson; Anna Lasorella; Antonio Iavarone
Journal:  Nat Cancer       Date:  2021-01-11

4.  Efficient representations of tumor diversity with paired DNA-RNA aberrations.

Authors:  Qian Ke; Wikum Dinalankara; Laurent Younes; Donald Geman; Luigi Marchionni
Journal:  PLoS Comput Biol       Date:  2021-06-11       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.